Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer, Director
-
Stock Symbol
-
BBIO on Nasdaq
Neil Kumar - trading volume in the past year for BridgeBio Pharma, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
4.95M |
$182M |
$36.87 |
Mar 25, 2025 |
By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. |
|
|
Common Stock |
996K |
$36.7M |
$36.87 |
Mar 25, 2025 |
By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. |
|
|
Common Stock |
212K |
$7.81M |
$36.87 |
Mar 25, 2025 |
Direct |
|
|
Restricted Stock Units |
185K |
$6.02M |
$32.58 |
Mar 19, 2025 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
71.2K |
|
|
Mar 19, 2025 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.